A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma.
Piro G, Simionato F, Carbone C, Frizziero M, Malleo G, Zanini S, Casolino R, Santoro R, Mina MM, Zecchetto C, Merz V, Scarpa A, Bassi C, Tortora G, Melisi D.
Piro G, et al. Among authors: frizziero m.
Oncoimmunology. 2017 Apr 28;6(9):e1322242. doi: 10.1080/2162402X.2017.1322242. eCollection 2017.
Oncoimmunology. 2017.
PMID: 28932629
Free PMC article.